Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TETRA-pilot
2021-005344-30Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AndroForte in Hypoandrogenism (TD), sponsored by Amsterdam University Medical Center. Primary endpoint: Total testosterone level. Started May 2022; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2021-005344-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005344-30.